Asthma and Stepwise Management PowerPoint

Asthma and Stepwise Management PowerPoint
Long-term Control Options for Asthma Patients
Work over time to:
Stop symptoms
Reduce airways swelling
Relax the muscle bands around airways
Long-term control medications include
Anti-inflammatory drugs
Bronchodilators
ORDER A PLAGIARISM-FREE PAPER HERE
Anti-inflammatory drugs:
Prevent asthmatic symptoms
Reduce swelling in the airways in case of a trigger
Control mucus in to ease breathing
Long-term Control Options for Asthma Patients Cont.
Examples of anti-inflammatory drugs are:
Inhaled corticosteroids
uCromolyn sodium
Montelukast
Zafirlukast
Zileuton
Bronchodilators taken together with anti-inflammatory drugs to:
Ease breathing by relaxing muscles around airways
Asthma and Stepwise Management PowerPoint
Examples of bronchodilators:
uInhaled long-acting beta2-agonists
uCombination inhalers
uTheophylline
uQuick Relief Treatment Options for Asthma Patients
uUsed to rapidly relieve flaring asthma symptoms
uWork by:
uLoosening tight muscles around airways to allow air to flow
uRapidly relaxes airways to ease breathing
uRelieves swelling in the airways
uExamples of short-term asthma treatments:
uInhaled short-acting beta2 agonists
uIpratropium (Atrovent)
uCorticosteroids.
u
uLong-term Effects of Asthma Medications
uEffects of corticosteroids include:
uDermal thinning
uDiabetes
uHigh blood pressure
uGrowth suppression
uEffects of inhaled long-acting beta2-agonists are:
uIncreased heart rate
uHypokalemia
uShakiness
uThe Stepwise Approach to Asthma Treatment and Management
u1st step: Mild intermittent symptoms & recommended drugs are short-acting beta-agonist like albuterol prn
u2nd step: Mild persistent asthma & drugs are low-dose inhaled corticosteroids & alternatively leukotriene blocker or cromolyn
u3rd & 4th steps: Moderate & severe asthma. The dose of inhaled corticosteroid is either increased or LABA added or both for step 4
u5th & 6th steps: Dose of inhaled corticosteroids is further increased & omalizumab can be added. In 6th step, oral/chronic corticosteroids are considered
uImportance of stepwise management to health care providers & patients
uProvides written action plans to guide patients how to control of asthmatic attack or exacerbations
uAllows providers to develop patient-tailored treatment plans
uAllows prompt management of any change in patient’s condition
uAdjusting drugs stepwise helps patients to gain & maintain control of the disease proces
uReferences
uEfraij K & Mark F. (2015). Current and emerging treatments for severe asthma. J Thorac Dis. 7(11), E522–E525.
uHorak F, Daniel D, Eber E, Horak E, Pohl W, osef R, et al. (2016). Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr. 128(15), 541–554.
uAnise A & Romana H. (2016). Patient-centered outcomes research to improve asthma outcomes. Clinical reviews in allergy and immunology. 138(6), 1503–1510.
uReddel H, Eric B, Becker A, Cruz A, Drazen J et al. (2015). A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 46(3), 622–639.
 
Reflect on drugs used to treat asthmatic patients, including long-term control and quick relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.
Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.
Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease.
Create a 5- to 6-slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following: Asthma and Stepwise Management PowerPoint
ASSIGNMENT:
Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
RUBRIC:
Describe the long-term control and quick relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient. Asthma and Stepwise Management PowerPoint
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
Written Expression and Formatting – Paragraph Development and Organization:
Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.
Written Expression and Formatting – English writing standards:
Correct grammar, mechanics, and proper punctuation Asthma and Stepwise Management PowerPoint
 
uAsthma and Stepwise Management
uLong-term Control Options for Asthma Patients
uWork over time to:
uStop symptoms
uReduce airways swelling
uRelax the muscle bands around airways
uLong-term control medications include
uAnti-inflammatory drugs
uBronchodilators
uAnti-inflammatory drugs:
uPrevent asthmatic symptoms
uReduce swelling in the airways in case of a trigger
Asthma and Stepwise Management PowerPoint
uControl mucus in to ease breathing
uLong-term Control Options for Asthma Patients Cont.
uExamples of anti-inflammatory drugs are:
uInhaled corticosteroids
uCromolyn sodium
uMontelukast
uZafirlukast
uZileuton
uBronchodilators taken together with anti-inflammatory drugs to:
uEase breathing by relaxing muscles around airways
Asthma and Stepwise Management PowerPoint
uExamples of bronchodilators:
uInhaled long-acting beta2-agonists
uCombination inhalers
uTheophylline
uQuick Relief Treatment Options for Asthma Patients
uUsed to rapidly relieve flaring asthma symptoms
uWork by:
uLoosening tight muscles around airways to allow air to flow
uRapidly relaxes airways to ease breathing
uRelieves swelling in the airways
uExamples of short-term asthma treatments:
uInhaled short-acting beta2 agonists
uIpratropium (Atrovent)
uCorticosteroids.
u
uLong-term Effects of Asthma Medications
uEffects of corticosteroids include:
uDermal thinning
uDiabetes
uHigh blood pressure
uGrowth suppression
uEffects of inhaled long-acting beta2-agonists are:
Asthma and Stepwise Management PowerPoint
uIncreased heart rate
uHypokalemia
uShakiness
uThe Stepwise Approach to Asthma Treatment and Management
u1st step: Mild intermittent symptoms & recommended drugs are short-acting beta-agonist like albuterol prn
u2nd step: Mild persistent asthma & drugs are low-dose inhaled corticosteroids & alternatively leukotriene blocker or cromolyn
u3rd & 4th steps: Moderate & severe asthma. The dose of inhaled corticosteroid is either increased or LABA added or both for step 4
u5th & 6th steps: Dose of inhaled corticosteroids is further increased & omalizumab can be added. In 6th step, oral/chronic corticosteroids are considered
uImportance of stepwise management to health care providers & patients
uProvides written action plans to guide patients how to control of asthmatic attack or exacerbations
uAllows providers to develop patient-tailored treatment plans
uAllows prompt management of any change in patient’s condition
uAdjusting drugs stepwise helps patients to gain & maintain control of the disease proces
uReferences
uEfraij K & Mark F. (2015). Current and emerging treatments for severe asthma. J Thorac Dis. 7(11), E522–E525.
uHorak F, Daniel D, Eber E, Horak E, Pohl W, osef R, et al. (2016). Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr. 128(15), 541–554.
uAnise A & Romana H. (2016). Patient-centered outcomes research to improve asthma outcomes. Clinical reviews in allergy and immunology. 138(6), 1503–1510.
uReddel H, Eric B, Becker A, Cruz A, Drazen J et al. (2015). A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 46(3), 622–639.
u

Is this the question you were looking for? If so, place your order here to get started!